Mary Bear - Imperva Senior Vice President - Cloud Services
President
Ms. Mary Bear serves as Senior Vice President and General Manager of Cloud Services of Imperva, Inc. since September 2015. Meg brings more than 20 years experience in all aspects of the software business. She is a customer experience and cloud industry thought leader, and holds eleven patents for innovations in data management, social business, recruitment and talent management. She is a frequent speaker and domain expert in cloud, helping companies adapt to the shift toward customercentric business models. Most recently, Meg was Group Vice President for Social Cloud at Oracle responsible for delivering an integrated global social suite. Previously, she held several product leadership roles within Oracle, including Vice President of Human Capital Management Development and Senior Director of Development for Oracle PeopleSoft. Prior to joining Oracle via the PeopleSoft acquisition she headed up engineering at SmartDB Software and later at Saba. In her career, Meg has also advised emerging enterprises by providing technical, business and industry advisory services. She currently serves as an Advisory Board Member at Unitive and Brand Amper, and previously served as Advisory Board Member at Storyvite. She has also held advisory roles with organizations including Watermark, TEDxSanJose, and IHRIM Publications. Meg is a graduate of the University of Arizona with a degree in Economics and Entrepreneurship. since 2015.
Age | 43 |
Tenure | 9 years |
Phone | 650 345-9004 |
Web | www.imperva.com |
Imperva Management Efficiency
The company has return on total asset (ROA) of 0.0474 % which means that it generated a profit of $0.0474 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0812 %, meaning that it created $0.0812 on every $100 dollars invested by stockholders. Imperva's management efficiency ratios could be used to measure how well Imperva manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 621.95 K in liabilities with Debt to Equity (D/E) ratio of 0.36, which is about average as compared to similar companies. Imperva has a current ratio of 2.0, which is within standard range for the sector. Debt can assist Imperva until it has trouble settling it off, either with new capital or with free cash flow. So, Imperva's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Imperva sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Imperva to invest in growth at high rates of return. When we think about Imperva's use of debt, we should always consider it together with cash and equity.
Similar Executives
Found 14 records | PRESIDENT Age | ||
Tadashi Motoi | HUTCHMED DRC | 56 | |
Jason Gottlieb | Artisan Partners Asset | 54 | |
Byron Finn | SunLink Health Systems | 68 | |
Yuichi Tsujimoto | HUTCHMED DRC | 60 | |
Hiroshi Tokushige | HUTCHMED DRC | 64 | |
James Hamman | Artisan Partners Asset | 54 | |
Leo Pavliv | Cumberland Pharmaceuticals | 54 | |
Amy Rock | Cumberland Pharmaceuticals | N/A | |
Sheila Brockman | SunLink Health Systems | 64 | |
Eileen Kwei | Artisan Partners Asset | 45 | |
Morio Sumiya | HUTCHMED DRC | 55 | |
Koji Sumioka | HUTCHMED DRC | 59 | |
Sarah Johnson | Artisan Partners Asset | 52 | |
Dean Patenaude | Artisan Partners Asset | 52 |
Management Performance
Return On Equity | 0.0812 | |||
Return On Asset | 0.0474 |
Imperva Leadership Team
Elected by the shareholders, the Imperva's board of directors comprises two types of representatives: Imperva inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Imperva. The board's role is to monitor Imperva's management team and ensure that shareholders' interests are well served. Imperva's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Imperva's outside directors are responsible for providing unbiased perspectives on the board's policies.
Charles Giancarlo, Director | ||
Tram Phi, Senior Vice President General Counsel, Corporate Secretary | ||
Randall Spratt, Director | ||
Christopher Hylen, President CEO, Director | ||
David Gee, Chief Marketing Officer | ||
Theresia Ranzetta, Independent Director | ||
Terrence Schmid, CFO, Principal Accounting Officer and Treasurer | ||
Mark Kraynak, Sr. VP and General Manager of The Enterprise Solutions Group | ||
Michael Mooney, Chief Revenue Officer | ||
Meg Bear, Senior Vice President - Cloud Services | ||
Amichai Shulman, Co-Founder, CTO and CTO of Imperva LTD | ||
Anthony Bettencourt, CEO and President and Director | ||
Mary Bear, Senior Vice President - Cloud Services | ||
Allan Tessler, Director | ||
Mike Burns, CFO | ||
Frank Slootman, Independent Director | ||
Brett Hooper, Senior Vice President - People | ||
David Woodcock, Senior Vice President of Worldwide Sales | ||
Terry Ray, CTO | ||
Kim DeCarlis, Chief Marketing Officer | ||
Albert Pimentel, Independent Director | ||
Aaron Kuan, Interim CFO | ||
Roger Sippl, Director | ||
Yaniv Shaya, Senior Vice President - Engineering of Imperva, Ltd. | ||
Sunil Nagdev, Senior Vice President Worldwide Services and Suppor | ||
James Tolonen, Director | ||
Geraldine Elliott, Director |
Imperva Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Imperva a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0812 | |||
Return On Asset | 0.0474 | |||
Profit Margin | 0.07 % | |||
Operating Margin | (2.24) % | |||
Current Valuation | 1.65 B | |||
Shares Outstanding | 35.44 M | |||
Shares Owned By Insiders | 1.17 % | |||
Shares Owned By Institutions | 98.83 % | |||
Number Of Shares Shorted | 1.68 M | |||
Price To Earning | 73.13 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Imperva in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Imperva's short interest history, or implied volatility extrapolated from Imperva options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in Imperva Stock
If you are still planning to invest in Imperva check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Imperva's history and understand the potential risks before investing.
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |